1921
Volume 92, Issue 6
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract.

The uniform multidrug therapy clinical trial, Brazil (U-MDT/CT-BR), database was used to describe and report the performance of available tools to classify 830 leprosy patients as paucibacillary (PB) and multibacillary (MB) at baseline. In a modified Ridley and Jopling (R&J) classification, considering clinical features, histopathological results of skin biopsies and the slit-skin smear bacterial load results were used as the gold standard method for classification. Anti-phenolic glycolipid-I (PGL-I) serology by ML Flow test, the slit skin smear bacterial load, and the number of skin lesions were evaluated. Considering the R&J classification system as gold standard, ML Flow tests correctly allocated 70% patients in the PB group and 87% in the MB group. The classification based on counting the number of skin lesions correctly allocated 46% PB patients and 99% MB leprosy cases. Slit skin smears properly classified 91% and 97% of PB and MB patients, respectively. Based on U-MDT/CT-BR results, classification of leprosy patients for treatment purposes is unnecessary because it does not impact clinical and laboratories outcomes. In this context, the identification of new biomarkers to detect patients at a higher risk to develop leprosy reactions or relapse remains an important research challenge.

Loading

Article metrics loading...

The graphs shown below represent data from March 2017
/content/journals/10.4269/ajtmh.14-0049
2015-06-03
2020-10-21
Loading full text...

Full text loading...

/deliver/fulltext/14761645/92/6/1280.html?itemId=/content/journals/10.4269/ajtmh.14-0049&mimeType=html&fmt=ahah

References

  1. Ridley DS, Jopling WH, 1966. Classification of leprosy according to immunity. A five-group system. Int J Lepr Other Mycobact Dis 34: 255273.
    [Google Scholar]
  2. WHO, 2012. WHO Expert Committee on Leprosy: Eighth Report. Geneva, Switzerland: WHO.
    [Google Scholar]
  3. ILA, 2002. Report of the International Leprosy Association Technical Forum. Paris, France, February 22–28, 2002: the diagnosis and classification of leprosy. Int J Lepr Other Mycobact Dis 70 (Suppl 1): S23S31.
    [Google Scholar]
  4. Penna GO, Pontes MAA, Cruz R, Goncalves HS, Penna MLF, Bührer-Sékula S, 2012. A clinical trial for uniform multidrug therapy for leprosy patients in Brazil: rationale and design. Mem Inst Oswaldo Cruz 107 (Suppl 1): 2227.[Crossref]
    [Google Scholar]
  5. Penna MLF, Buhrer-Sékula S, Pontes MAA, Cruz R, Gonçalves HDS, Penna GO, 2012. Primary results of clinical trial for uniform multidrug therapy for leprosy patients in Brazil (U-MDT/CT-BR): reactions frequency in multibacillary patients. Lepr Rev 83: 308319.
    [Google Scholar]
  6. Moura RS, Calado KL, Oliveira ML, Bührer-Sékula S, 2008. Leprosy serology using PGL-I: a systematic review. Rev Soc Bras Med Trop 41 (Suppl 2): 1118.[Crossref]
    [Google Scholar]
  7. Oskam L, Slim E, Bührer-Sékula S, 2003. Serology: recent developments, strengths, limitations and prospects: a state of the art overview. Lepr Rev 74: 196205.
    [Google Scholar]
  8. Parkash O, Kumar A, Pandey R, Nigam A, Girdhar BK, 2008. Performance of a lateral flow test for the detection of leprosy patients in India. J Med Microbiol 57: 130132.[Crossref]
    [Google Scholar]
  9. Bobosha K, Tjon Kon Fat EM, van den Eeden SJF, Bekele Y, van der Ploeg-van Schip JJ, de Dood CJ, Dijkman K, Franken KLMC, Wilson L, Aseffa A, Spencer JS, Ottenhoff THM, Corstjens PLAM, Geluk A, 2014. Field-evaluation of a new lateral flow assay for detection of cellular and humoral immunity against Mycobacterium leprae . PLoS Negl Trop Dis 8: e2845.[Crossref]
    [Google Scholar]
  10. Lockwood DNJ, Nicholls P, Smith WCS, Das L, Barkataki P, van Brakel W, Suneetha S, 2012. Comparing the clinical and histological diagnosis of leprosy and leprosy reactions in the INFIR cohort of Indian patients with multibacillary leprosy. PLoS Negl Trop Dis 6: e1702.[Crossref]
    [Google Scholar]
  11. Kumar B, Dogra S, Kaur I, 2004. Epidemiological characteristics of leprosy reactions: 15 years experience from north India. Int J Lepr Other Mycobact Dis 72: 125133.[Crossref]
    [Google Scholar]
  12. Baohong J, 2001. Does there exist a subgroup of MB patients at greater risk of relapse after MDT? Lepr Rev 72: 37.
    [Google Scholar]
  13. Bührer-Sékula S, Smits HL, Gussenhoven GC, van Leeuwen J, Amador S, Fujiwara T, Klatser PR, Oskam L, 2003. Simple and fast lateral flow test for classification of leprosy patients and identification of contacts with high risk of developing leprosy. J Clin Microbiol 41: 19911995.[Crossref]
    [Google Scholar]
  14. Landis JR, Koch GG, 1977. The measurement of observer agreement for categorical data. Biometrics 33: 159174.[Crossref]
    [Google Scholar]
  15. Penna MLF, Buhrer-Sékula S, Pontes MAA, Cruz R, Gonçalves HS, Penna GO, 2014. Results from the clinical trial of uniform multidrug therapy for leprosy patients in Brazil (U-MDT/CT-BR): decrease in bacteriological index. Lepr Rev 85: 262266.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.14-0049
Loading
/content/journals/10.4269/ajtmh.14-0049
Loading

Data & Media loading...

  • Received : 21 Jan 2014
  • Accepted : 18 Feb 2015
  • Published online : 03 Jun 2015
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error